NUVISAN The Science CRO
Maximilian Koy is a Scientist and Lab Head at Nuvisan, specializing in hit-to-lead and lead optimization, miniaturization, and automatization of reactions, and direct-to-biology. Prior to their current role, Maximilian was a Postdoctoral Researcher at Rijksuniversiteit Groningen and a Doctoral Researcher at Universität Münster, focusing on methodology development, organic synthesis, transition-metal catalysis, and heterogeneous catalysis. Maximilian also has experience as a Scientific Assistant at Universität Stuttgart and a Research Intern at Caltech. Maximilian holds a Dr. rer. nat. (PhD) in Organic Chemistry from the University of Münster.
This person is not in the org chart
NUVISAN The Science CRO
1 followers
Founded in Europe with more than 40 years of experience, NUVISAN is a fully integrated contract research and development, and manufacturing organization (CRO/CDMO) that offers unique, high-quality, and tailored integrated solutions along the drug discovery and development value chain. With more than 1.000 employees distributed over six locations in Germany and France including our drug discovery hub in Berlin as well as with local experts situated in Latin America, NUVISAN is pleased to offer the following portfolio of services: • Drug discovery & research - Discovery pharmacology - Discovery bioscience - Screening - Life science chemistry - Translation research - Digital life science - Toxicology - DMPK • Non-clinical studies • Pharmaceutical analysis • Topical formulation development • Chemical development with GMP manufacturing (3-10kg) • Bioanalytical labs • GMP manufacturing (up to 50Kg) • Clinical trial supplies • Phase 1 and 2 clinical studies and beyond Our services can be provided as stand-alone or integrated solutions and can be customized to your project. Email us at hello@nuvisan.com for more.